Institutional investors purchased a net $2.0 million shares of SPNC during the quarter ended March 2015 and now own 111.86% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAMCO, INC. Bought 592.3 Thousand shares of Spectranetics Corp